{"filing":{"accession_number":"0001104659-26-117576","cik":"0001140859","ticker":"COR","company_name":"Cencora, Inc.","form":"8-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"tm2627778d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1140859/000110465926117576/tm2627778d1_8k.htm"},"events":[{"id":36601,"run_id":33748,"accession_number":"0001104659-26-117576","anchor_item_number":"2.02","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.97,"summary":"Cencora announced a definitive agreement to acquire American Oncology Network (AON) for an enterprise value of $2.4 billion ($2.3 billion at closing plus up to $100 million in contingent value rights), with Cencora paying approximately $1.7 billion to increase its ownership from 4% to 75%. The acquisition expands Cencora's physician-led oncology MSO platform across twelve additional states and is subject to regulatory and stockholder approvals.","company_name":"Cencora, Inc.","ticker":"COR","filing_date":"2026-10-21","form":"8-K","submitted_at":null,"items":[{"id":41065,"accession_number":"0001104659-26-117576","item_number":"2.02","item_title":"Results of Operations and Financial","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Cencora announced a definitive agreement to acquire American Oncology Network (AON) for an enterprise value of $2.4 billion ($2.3 billion at closing plus up to $100 million in contingent value rights), with Cencora expecting to pay approximately $1.7 billion to increase its ownership to 75%. This is a material acquisition that expands Cencora's physician-led oncology MSO platform across twelve additional states and represents a significant capital deployment and strategic transaction subject to regulatory and stockholder approvals.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T11:49:39.952740+00:00","company_name":"","ticker":null,"filing_date":""},{"id":41066,"accession_number":"0001104659-26-117576","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"Cencora announced entry into a definitive Agreement and Plan of Merger to acquire American Oncology Network (AON) for an enterprise value of $2.4 billion, with Cencora paying approximately $1.7 billion to increase its ownership from 4% to 75%. This is a material acquisition disclosed via news release on October 21, 2026, representing a significant M\u0026A transaction that would materially affect investor assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T11:49:39.952740+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41065,"accession_number":"0001104659-26-117576","item_number":"2.02","item_title":"Results of Operations and Financial","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Cencora announced a definitive agreement to acquire American Oncology Network (AON) for an enterprise value of $2.4 billion ($2.3 billion at closing plus up to $100 million in contingent value rights), with Cencora expecting to pay approximately $1.7 billion to increase its ownership to 75%. This is a material acquisition that expands Cencora's physician-led oncology MSO platform across twelve additional states and represents a significant capital deployment and strategic transaction subject to regulatory and stockholder approvals.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T11:49:39.952740+00:00","company_name":"Cencora, Inc.","ticker":"COR","filing_date":"2026-10-21"},{"id":41066,"accession_number":"0001104659-26-117576","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"Cencora announced entry into a definitive Agreement and Plan of Merger to acquire American Oncology Network (AON) for an enterprise value of $2.4 billion, with Cencora paying approximately $1.7 billion to increase its ownership from 4% to 75%. This is a material acquisition disclosed via news release on October 21, 2026, representing a significant M\u0026A transaction that would materially affect investor assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T11:49:39.952740+00:00","company_name":"Cencora, Inc.","ticker":"COR","filing_date":"2026-10-21"}]}